
### [NCIT:C3640](http://purl.obolibrary.org/obo/NCIT_C3640)
**Label:** Stage 0 Skin Cancer

**Subclasses:** [NCIT:C62571](http://purl.obolibrary.org/obo/NCIT_C62571) (Bowen Disease of the Skin), [NCIT:C5893](http://purl.obolibrary.org/obo/NCIT_C5893) (Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7), [NCIT:C2906](http://purl.obolibrary.org/obo/NCIT_C2906) (Skin Squamous Cell Carcinoma In Situ), 

**Class expressions from DL-Learner:**

- Thing 53.40%
- [NCIT:C47805](http://purl.obolibrary.org/obo/NCIT_C47805) (Malignant Neuroendocrine Small Round Cell) 52.78%
- [NCIT:C28079](http://purl.obolibrary.org/obo/NCIT_C28079) (Grade 3) 52.78%
- [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 38.13%


